deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01719692

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia (ITP)

Prospective Multi-center Randomized Controlled Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Sponsor: Henan Cancer Hospital

Conditions Immune Thrombocytopenic Purpura
Interventions Rituximab
Updated 9 times since 2017 Last updated: Feb 9, 2026 Started: Oct 31, 2012 Primary completion: Oct 31, 2015 Completion: Feb 29, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01719692, this NA trial focuses on Immune Thrombocytopenic Purpura and remains completed. Sponsored by Henan Cancer Hospital, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshotUnknown Status~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Oct 2023 · 33 months · monthly snapshotCompleted~Oct 2023 – ~Apr 2024 · 6 months · monthly snapshotCompleted~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotCompleted~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed NA

  2. Sep 2024 — Feb 2026 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Apr 2024 — Jul 2024 [monthly]

    Completed NA

  5. Oct 2023 — Apr 2024 [monthly]

    Completed NA

▶ Show 4 earlier versions

  1. Jan 2021 — Oct 2023 [monthly]

    Completed NA

  2. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  3. Jun 2017 — Jun 2018 [monthly]

    Completed NA

    Status: Unknown Status → Completed

  4. Jan 2017 — Jun 2017 [monthly]

    Unknown Status NA

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Henan Cancer Hospital
  • Institute of Hematology & Blood Diseases Hospital, China
  • Langfang Traditional Chinese Medicine Hospital
  • The Second Affiliated Hospital of Kunming Medical University
Data source: Institute of Hematology & Blood Diseases Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations